← All organizations
Highest phase reached
Phase 1
First clinical trial
Jun 1, 2019Last known activity
Dec 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 1 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Recent trials (10)
- NCT06185218Lead sponsorN/ADec 31, 2023
- NCT05965544Overall official - principal investigatorN/AAug 2, 2023
- NCT05965544Reponsible party - principal investigatorN/AAug 2, 2023
- NCT05965544Lead sponsorN/AAug 2, 2023
- NCT05849571OfficialN/AMar 1, 2023
- NCT05849571Overall official - principal investigatorN/AMar 1, 2023
- NCT06838156Lead sponsorN/AFeb 15, 2023
- NCT06838156Sponsor investigatorN/AFeb 15, 2023
- NCT04886882Lead sponsorEarly Phase 1Mar 22, 2021
- NCT04720573Lead sponsorN/AJun 1, 2019
Details
- Last known activity
- Dec 31, 2023